Abstract
Neuropsychiatric adverse events have been reported in influenza patients with and without exposure to oseltamivir (Tamiflu), triggering speculation as to whether oseltamivir may be interacting with any human receptors and contributing to such neuropsychiatric events. In this study, the in vitro selectivity profile of oseltamivir prodrug and active metabolite was investigated. Both compounds lacked clinically relevant pharmacological activities on human, rodent and primate neuraminidases and on a panel of 155 other molecular targets, including those relevant for mood, cognition and behavior. Neuropsychiatric adverse events observed in influenza patients are likely a phenomenon caused by the infection rather than by oseltamivir.
References
Jan 11, 2000·Clinical Pharmacokinetics·G HeP Ward
Mar 7, 2000·Current Medicinal Chemistry·W LewC U Kim
Aug 13, 2002·Current Topics in Medicinal Chemistry·W Sieghart, G Sperk
Sep 30, 2005·The New England Journal of Medicine·Anne Moscona
Nov 2, 2005·Expert Opinion on Pharmacotherapy·John Oxford
May 30, 2006·The Pediatric Infectious Disease Journal·Akihisa OkumuraTsuneo Morishima
Apr 12, 2007·Cell Research·Chuan-Yun LiLiping Wei
Apr 26, 2007·Journal of Clinical Pharmacology·Jerome J SchentagCraig R Rayner
Jul 31, 2007·Future Microbiology·Jordi Vila, Robert A Bonomo
Sep 11, 2007·Biological & Pharmaceutical Bulletin·Kanako SatohShin-Ichi Uehara
Aug 13, 2008·Antimicrobial Agents and Chemotherapy·Keiko HataTaeko Miyagi
Citations
Oct 12, 2012·Advances in Therapy·Stephen TooveyBarbara Donner
Apr 23, 2013·Cell Reports·Yotam Bar-OnOfer Mandelboim
Dec 5, 2013·Drug Delivery·Yue TangJiabi Zhu
Jul 22, 2014·EJNMMI Research·Chie SekiTetsuya Suhara
Jan 17, 2013·British Journal of Pharmacology·Miki HiasaTakashi Kuzuhara
Feb 13, 2013·Basic & Clinical Pharmacology & Toxicology·Hideki OnoShohei Yamamoto
Feb 9, 2012·Basic & Clinical Pharmacology & Toxicology·Christian FreichelEric P Prinssen
May 20, 2011·Basic & Clinical Pharmacology & Toxicology·Naohisa UchimuraEric P Prinssen
Feb 7, 2015·Muscle & Nerve·Koji HayashiMasahito Yamada
Jun 27, 2014·Basic & Clinical Pharmacology & Toxicology·Katsuhiko MurakiHideki Ono
Jun 7, 2015·European Journal of Pharmacology·Akihiro FukushimaHideki Ono
May 20, 2015·Neuroscience Letters·Hidemori UchiyamaAkihisa Toda
Jun 3, 2016·Infectious Diseases·Rokuro Hama
Jul 2, 2016·Acta Neurologica Scandinavica·R Hama, C L Bennett
Jun 22, 2018·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hideki OnoAkihiro Fukushima
Oct 7, 2010·Clinical Pharmacokinetics·Nicolas WidmerThierry Buclin
May 8, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hideki Ono
Jan 22, 2011·Psychiatry Investigation·Sungho Chung, Yoo Sook Joung
Dec 3, 2020·Pharmaceutics·Shahir AzizHartwig Steckel
Nov 4, 2020·The Journal of Pharmacology and Experimental Therapeutics·Irina G LuzinaSimeon E Goldblum
Apr 4, 2021·Plants·Katalin Magyar-TáboriJudit Dobránszki